Kennedy disease with biphasic clinical course and rapid progression.

J Clin Neuromuscul Dis

*Department of Neurology, Madrid, Spain; †ALS-Neuromuscular Unit, Madrid, Spain; ‡Department of Clinical Neurophysiology, Madrid, Spain; and §Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Published: June 2014

We report a case of spinal and bulbar muscular atrophy (SBMA), also known as Kennedy disease, with a 38 CAG-repeat expansion in exon-1 of the androgen receptor gene, presenting with a 2-year history of mild speech difficulty, dysphonia, and occasional choking. Initial clinical features and complementary studies were consistent with SBMA. The disease progression, as assessed by the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised, remained stable over the first 5 years from the onset but showed a rapid decline (from 42 to 24 points) over the next 18 months before his death. In the later stages of the disease, deep tendon reflexes were preserved in limbs and a brisk jaw-jerk reflex and bilateral Hoffmann sign were evident. Survival from disease onset was 78 months. The final cause of death was aspiration pneumonia. The atypical clinical features, evolution, and accelerated disease course are not concordant with the relatively short 38 CAG-repeat expansion in the androgen receptor gene. This may represent either a variant SBMA phenotype, which has not been recorded to date, or the development of amyotrophic lateral sclerosis in a known case of SBMA.

Download full-text PDF

Source
http://dx.doi.org/10.1097/CND.0000000000000030DOI Listing

Publication Analysis

Top Keywords

kennedy disease
8
cag-repeat expansion
8
androgen receptor
8
receptor gene
8
clinical features
8
amyotrophic lateral
8
lateral sclerosis
8
disease
5
disease biphasic
4
biphasic clinical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!